期刊文献+

Mip3β、血型A抗原模拟多肽/Fas融合基因双表达重组质粒的构建及鉴定 被引量:1

暂未订购
导出
摘要 目的:构建Mip3β、血型A抗原模拟多肽/Fas融合基因双表达重组质粒。方法:通过RT-PCR的方法从扁桃体中扩增的Mip3β基因片段,然后将基因工程合成的血型A抗原模拟多肽/Fas融合基因经双酶切后分别连接至pIRES质粒,测序验证碱基序列。结果:扩增出了Mip3β的全长CDNA,并成功构建Mip3β、血型A抗原模拟多肽/Fas融合基因双表达重组质粒,测序结果正确。结论:成功构建了Mip3β、血型A抗原模拟多肽/Fas融合基因双表达重组质粒,为进一步探讨血型抗原模拟多肽对肿瘤微环境的影响奠定分子学基础。
出处 《实用医学杂志》 CAS 北大核心 2011年第4期569-571,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献10

  • 1Fukushima S,Hirata S,Motomura Y,et al.Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells[J].J Immunother,2009,32(3):219-231.
  • 2Wen B.DNA vaccines and cancer immunity[J].For Med Sci,2003,26(1):17-19.
  • 3Liakou C I,Narayanan S,Ng Tang D,et al.,Focus on TILs:Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer[J].Cancer Immun,2007,7:10.
  • 4Gajewski T F,Meng Y,Harlin H,et al.Immune suppression in the tumor microenvironment[J].J Immunother,2006,29(3):233-240.
  • 5Galili U,Wigglesworth K,Abdel-Motal U M.Intratumoral injection of alpha-gal glycolipids induces xenograf-like destruction and conversion of lesions into endogenous vaccines[J].J Immunol,2007,178(7):4676-4687.
  • 6Barenholz A,Hovav A H,Fishman Y,et al.A peptide mimetic of the mycobacterial mannosylated lipoarabinomannan:characterization and potential applications[J].J Med Microbiol,2007,56(Pt 5):p579-586.
  • 7Gevorkian G,Segura E,Acero G,et al.Peptide mimotopes of Mycobacterium tuberculosis carbohydrate immunodeterminants[J].Biochem J,2005,387(Pt 2):p411-417.
  • 8Sharma A,Saha A,Bhattacharjee S,et al.Specific and randomly derived immunoactive peptide mimotopes of mycobacterial antigens[J].Clin Vaccine Immunol,2006,13(10):1143-1154.
  • 9Gordon N,Kleinerman E S.The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases[J].Cancer Treat Res,2010,152:497-508.
  • 10孙麟,陈乔尔.Fas/FasL凋亡系统与肿瘤免疫逃逸研究进展[J].医学综述,2008,14(6):833-835. 被引量:19

二级参考文献18

  • 1向青,徐波,徐梅.Fas/FasL途径介导的人肺癌细胞免疫逃逸[J].中国病理生理杂志,2006,22(1):168-171. 被引量:15
  • 2宿杰,田大力,陈东义,张林,孙丽华.Fas/FasL在小细胞肺癌和转移淋巴结中的表达及临床意义[J].中国医科大学学报,2006,35(3):282-283. 被引量:5
  • 3刘晓红,王心明,王延龄.Fas/FasL在乳腺疾病发生发展过程中作用的研究[J].中国实验诊断学,2007,11(2):158-162. 被引量:10
  • 4Griffith TS,Brunner T, Fletcher SM,et al. Fas ligand-induced apoptosis as a mechanism of immune privilege [ J ]. Science, 1995, 270 ( 5239 ) : 1189-1192.
  • 5Husain N,Chiocca EA. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines [ J ]. Acta Neuropathol Berl, 1998,95 (3) :287-290.
  • 6Strater J, Hinz U ,Hasel C ,et al. Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95 L mediated control of minimal residual disease [ J ]. Gut,2005,54 (5) :661-665.
  • 7Munakata S, Watanabe O, Ohashi K, et al. Expression of FasL and Bcl-2 in cervical carcinoma and their prognostic significance [ J ]. Am J Clin Pathol,2005,123 (6) :879-885.
  • 8Reimer T, Kocran D, Muller H, et al. Tumor Fas ligand : Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer [ J ]. Breast Cancer Res,2002,4(5) :R9.
  • 9Lee WC, Yu WC, Chen MF. Prognostic impact of Fas llgand on hepatocellular carcinoma after hepatectomy [ J]. World J Surg, 2004,28(8) :792-796.
  • 10Chakraborty M, Abrams SI, Coleman CN,et al. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing[ J ]. Cancer Res.2004, 64(12) :4328-4337.

共引文献18

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部